| |
| |
|
| Insider
Information: |
Brennan Daniel J. |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
272,248 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,358,775 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
272,248 |
|
|
| Total
Value |
$20,358,775 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 8.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP and CFO |
2024-02-20 |
271,542 |
|
0 |
Premium* |
|
|
Nuance Communications Inc |
NUAN |
Director |
2022-03-04 |
0 |
2018-09-10 |
0 |
Premium* |
|
|
Waters Corp |
WAT |
Director |
2024-01-02 |
706 |
2022-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-02-23 |
4 |
D |
$40.52 |
$96,640 |
D/D |
(2,385) |
319,870 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,365 |
322,255 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-02-24 |
4 |
D |
$40.52 |
$103,285 |
D/D |
(2,549) |
323,055 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,734 |
325,604 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-02-28 |
4 |
D |
$40.12 |
$79,919 |
D/D |
(1,992) |
325,543 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,480 |
327,535 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-03-04 |
4 |
AS |
$40.84 |
$2,622,553 |
D/D |
(64,223) |
261,320 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-03-14 |
4 |
AS |
$40.02 |
$1,855,545 |
D/D |
(46,360) |
214,960 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-10-02 |
4 |
AS |
$39.44 |
$807,040 |
D/D |
(20,462) |
214,960 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2019-10-02 |
4 |
OE |
$7.41 |
$151,623 |
D/D |
20,462 |
235,422 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,865 |
236,825 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-01-01 |
4 |
D |
$45.22 |
$297,457 |
D/D |
(6,578) |
230,247 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-13 |
4 |
AS |
$42.03 |
$860,041 |
D/D |
(20,463) |
230,247 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-13 |
4 |
OE |
$7.41 |
$151,631 |
D/D |
20,463 |
250,710 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
36,964 |
267,211 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-14 |
4 |
D |
$42.31 |
$710,004 |
D/D |
(16,781) |
250,430 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-15 |
4 |
D |
$42.31 |
$79,797 |
D/D |
(1,886) |
252,697 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,153 |
254,583 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-21 |
4 |
D |
$42.62 |
$70,749 |
D/D |
(1,660) |
254,697 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,660 |
256,357 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,794 |
260,491 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-22 |
4 |
D |
$42.62 |
$112,005 |
D/D |
(2,628) |
257,863 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-23 |
4 |
D |
$42.62 |
$103,694 |
D/D |
(2,433) |
260,795 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,365 |
263,228 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-28 |
4 |
D |
$37.39 |
$76,014 |
D/D |
(2,033) |
263,243 |
0 |
- |
|
169 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
